I wonder if Onyx can leverage this data to make inroads in kidney cancer? Make some kind of bizarre "look what it did to the liver cancer patients so do you really want to give your kidney cancer patients this drug?" type of approach?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.